Literature DB >> 2682948

Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease.

R M Genta1.   

Abstract

Opportunistic disseminated strongyloidiasis is an important cause of morbidity and mortality in immunocompromised patients. However, the worldwide prevalence of Strongyloides stercoralis is difficult to determine because adequate data are lacking. In this paper more than 100 epidemiologic studies reporting on the prevalence of S. stercoralis among various populations on five continents are critically reviewed. Analysis of this information indicates that the following groups of people may be at risk: residents of an emigrants from any developing country and southern, eastern, and central Europe; travelers and veterans returning from endemic areas; natives and residents of the Appalachian region in the United States and local endemic areas in other countries; and institutionalized persons. Because disseminated infections may be prevented by early treatment of asymptomatic chronic infections, screening programs are recommended to detect latent S. stercoralis infection before the initiation of chemotherapy or immunosuppression in patients at risk. Serologic tests are sensitive and specific but are not yet widely available. Thus strong suspicion based on clinical and epidemiologic clues in conjunction with repeated stool examinations remains the best way to rule out S. stercoralis infection in these groups.

Entities:  

Mesh:

Year:  1989        PMID: 2682948     DOI: 10.1093/clinids/11.5.755

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  93 in total

Review 1.  Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host.

Authors:  F Friedenberg; N Wongpraparut; R A Fischer; J Gubernick; N Zaeri; G Eiger; Z Ozden
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

2.  First-glance diagnosis of Strongyloides stercoralis autoinfection by stool microscopy.

Authors:  A Sing; L Leitritz; J R Bogner; J Heesemann
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 3.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

4.  Strongyloides infection in a cardiac transplant recipient: making a case for pretransplantation screening and treatment.

Authors:  Inderpreet S Grover; Rene Davila; Charu Subramony; Sumanth R Daram
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

5.  Strongyloides stercoralis hyperinfection syndrome and disseminated disease.

Authors:  Marco Kassalik; Klaus Mönkemüller
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-11

6.  Strongyloides stercoralis infection in a patient with sickle cell disease.

Authors:  D E Ferastraoaru; N N Jariwala; S P Jariwala
Journal:  Ann Trop Med Parasitol       Date:  2011-12

7.  Comparative assessment of the gelatin particle agglutination test and an enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis.

Authors:  J Sithithaworn; P Sithithaworn; T Janrungsopa; K Suvatanadecha; K Ando; M R Haswell-Elkins
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.

Authors:  Tatvam T Choksi; Gul Madison; Tawseef Dar; Mohammed Asif; Kevin Fleming; Leon Clarke; Mervyn Danilewitz; Randa Hennawy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

Review 9.  Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.

Authors:  Sue Lim; Kevin Katz; Sigmund Krajden; Milan Fuksa; Jay S Keystone; Kevin C Kain
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

Review 10.  Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.

Authors:  Rada Miskovic; Aleksandra Plavsic; Jasna Bolpacic; Sanvila Raskovic; Jovan Ranin; Mirjana Bogic
Journal:  Rheumatol Int       Date:  2018-10-23       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.